Cognitive function and blood pressure control in hypertensive patients over 60 years of age: COGNIPRES study

References

• Rigaud AS, Forette B. Hypertension in older adults. J Gerontol A Biol Sci Med Sci 2001;56:M217-225
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanism in ischemic stroke pathogenesis and implications for therapy. Stroke 2002;33:862-75
   PubMed Web of Science ®Google Scholar
• The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (VI JNC). Arch Intern Med 1997;157:2413-46
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7-Complete Version. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO/International Society of hypertension (ISH) statement of hypertension. J Hyperten 2003;21:1983-92
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9
   PubMed Web of Science ®Google Scholar
• De Groot JC, de Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-41
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Prins N, Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22
   PubMed Web of Science ®Google Scholar
• Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-41
   PubMed Web of Science ®Google Scholar
• Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-4
   PubMed Web of Science ®Google Scholar
• Rigaud AS, Hanon O, Seux ML, et al. Hypertension and dementia. Curr Hypertens Rep 2001;3:454-7
   PubMedGoogle Scholar
• Forette F, Amery A, Staessen J, et al. Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project. Aging 1991;3:373-82
   PubMedGoogle Scholar
• SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the elderly program (SHEP). JAMA 1991;265:3255-64
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41
   PubMed Web of Science ®Google Scholar
• Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51
   PubMed Web of Science ®Google Scholar
• Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998;31:780-86
   PubMed Web of Science ®Google Scholar
• Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75
   PubMed Web of Science ®Google Scholar
• Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature. Curr Med Res 2007;23:13-18
   Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
   PubMed Web of Science ®Google Scholar
• Torre J, Fernández R, López J, et al. [Treatment adherence and BP control study in urban population.]. Rev Clin Esp 1990;187:103-6
   PubMedGoogle Scholar
• Val A, Amorós G, Martínez P, et al. [Adherence to pharmacologic antihypertensive treatment and validation of Morisky-Green test descriptive study.]. Aten Prim 1992;10:767-70
   PubMedGoogle Scholar
• Gil VF, Pineda M, Martínez JL, et al. [Validity of 6 indirect methods to assess therapeutic adherence in HBP.]. Med Clin 1994;102:532-6
   PubMed Web of Science ®Google Scholar
• Practical aspects of drug treatment in elderly patients with mobility problems. Drugs Aging 1999;14:105-14
   PubMed Web of Science ®Google Scholar
• McCormack PME, Lawlor R, Donegan C, et al. Knowledge and attitudes to prescribed drugs in young and elderly patients. Irish Med J 2000;90:29-30
   Google Scholar
• Kyngas H, Lahdenpera T. Compliance of patients with hypertension and associated factors. J Adv Nurs 1999;29:832-9
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein S, McHugh RP. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
   Google Scholar
• García García FJ, Sánchez Ayala MI, Pérez Martín A, et al. [The prevalence of dementia and its main subtypes in subjects older than 65 years: the effects of occupation and education. Toledo Study.]. Med Clin (Barc) 2001;116:401-7
   PubMed Web of Science ®Google Scholar
• Escribano-Aparicio MV, Pérez-Dively M, García García FJ, et al. Validation of Folstein's MMSE in a Spanish low educated population. Rev Esp Geriatr Gerontol 1999;34:319-26
   Google Scholar
• Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64
   PubMed Web of Science ®Google Scholar
• Ferran M, Parcet J, Casabella B, et al. [Health education to hypertensive patients: proposal of an information and adherence test.]. Aten Prim 1988;5:25-30
   Google Scholar
• Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-51
   PubMed Web of Science ®Google Scholar
• Gustafson D, Rothenberg E, Blennow K, et al. An 18-year follow-up of overweight and risk of Alzheimer's disease. Arch Intern Med 2003;163:1524-8
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42:776
   PubMed Web of Science ®Google Scholar
• Quiu C, von Strauss E, Fastbom J, et al. Low blood pressure and risk of dementia in the Kungsholmen Project. A 6-year follow-up study. Arch Neurol 2003;60:223-8
   PubMed Web of Science ®Google Scholar
• Verghese J, Lipton RB, Hall CB, et al. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003;61:1667-72
   PubMed Web of Science ®Google Scholar
• Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke 2003;34:2617-22
   PubMed Web of Science ®Google Scholar
• Srikanth VK, Thrift AG, Saling MM, et al. Increased risk of cognitive impairment 3 months after mild to moderate first-ever stroke: a community-based prospective study of nonaphasic English-speaking survivors. Stroke 2003;34:1136-43
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22
   PubMed Web of Science ®Google Scholar
• Kuller LH. [Risk factors for dementia in the Cardiovascular Health Study cognition study.]. Rev Neurol 2003;37:122-6
   PubMed Web of Science ®Google Scholar
• Sakakura K, Hoshide S, Ishikawa J, et al. Association of body mass index with cognitive function in elderly hypertensive Japanese. Am J Hypertens 2008;21:627-32
   PubMed Web of Science ®Google Scholar
• Wolf PA, Beiser A, Elias MF, et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 2007;4:111-16
   PubMed Web of Science ®Google Scholar
• González Juanatey JR, Alegría Ezquerra E, Lozano Vidal JV, et al. [The role of high blood pressure in cardiac diseases in Spain. The CARDIOTENS Study 1999.]. Rev Esp Cardiol 2001;54:139-49
   Google Scholar
• Coca A. [Improvement on BP control in Spain: results from the CONTROLPRES 98 Study.]. Hipertensión 1998;15:298-306
   Google Scholar
• Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the health examinations surveys, 1960 to 1991. Hypertension 1995;26:60-69
   PubMed Web of Science ®Google Scholar
• Joffres MR, Gharidian P, Fodor JG, et al. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997;10:1097-102
   PubMed Web of Science ®Google Scholar
• Colhoun HM, Dong W, Poulter NR.Blood pressure screening, management and control in England: results from the Health Survey for England 1994. J Hypertens 1998;16:747-52
   PubMed Web of Science ®Google Scholar
• Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the “rule of halves” still valid? J Hum Hypertens 1997;111:213-20
   Google Scholar
• Llisterri Caro JL, Rodriguez Coca GC, Alonso Moreno FJ, et al. [Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study.]. Med Clin (Barc) 2004;122:165-71
   Google Scholar
• Coca A. [Blood pressure control among treated hypertensive patients by Primary Care in Spain. The 2003 Controlpres study.]. Hipertensión 2005;22:5-14
   Google Scholar
• Gil VF, Merino J. [Adherence: deciding factor in hypertensive patient treatment.]. Iberoam J Hypertens 1996;1(Suppl 2):13-17
   Google Scholar
• Piñeiro F, Gil VF, Donis M, et al. [Relation between medical treatment compliance and degree of control in patients with high blood pressure, non insulin dependent diabetes mellitus and hyperlipidemia.]. Med Clin (Barc) 1998;11:565-7
   Google Scholar
• Márquez Contreras E, Gil Guillén V. Estrategias para mejorar el cumplimiento terapéutico. In: De la Figuera M, Diogène E, Brotons C, eds. Hipertensión arterial en Atención Primaria. Evidencia y práctica clínica. 2nd edn, Barcelona, Euromedice 2007;265-313
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
   PubMed Web of Science ®Google Scholar
• Banegas JR, Rodríguez-Artalejo F, Ruilope LM, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertension 2002;20:2157-64
   PubMed Web of Science ®Google Scholar
• Obisesan TO, Obisesan OA, Martins S, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 2008;56:501-9
   PubMed Web of Science ®Google Scholar
• Forette F, Panisset M, Boller F. Clinical trials in cognitive impairment in the elderly. Aging 1992;4:239-50
   PubMedGoogle Scholar
• Basile JN, Chrysant S. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens 2006;20:169-75
   PubMed Web of Science ®Google Scholar
• Hanon O, Forette F. Prevention of dementia: lessons from SYST-EUR and PROGRESS. J Neur Sci 2004;226:71-4
   Web of Science ®Google Scholar
• Vilalta-Franch J, López Pousa S, Llinàs-Reglà J. [The prevalence of dementias in a rural area. A study in Girona.]. Rev Neurol 2000;30:1026-32
   PubMed Web of Science ®Google Scholar
• Ritchie K, Kildea D. Is senile dementia “age related” or “ageing related”?: evidences from meta-analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-4
   PubMed Web of Science ®Google Scholar
• Zunzunegui MV, del Ser T, Rodríguez A, et al. [Non-detected dementia and use of the health services: implications for primary care.]. Aten Primaria 2003;31(9):581-6
   PubMedGoogle Scholar
• Del Ser T, Morales JM, Barquero MS, et al. Application of a Spanish version of the “Informant Questionnaire on cognitive decline in the elderly” in the clinical assessment of dementia. Alzheimer Dis Assoc Disord 1997;11:3-8
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-17
   PubMed Web of Science ®Google Scholar
• 2007 Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2007;9. ( Suppl C):C3-74
   Google Scholar